title: Terbufos-sulfone exacerbates cardiac lesions in diabetic rats: a sub-acute toxicity study.
abstract: Organophosphorus compounds (OPCs) have a wide range of applications, from agriculture to warfare. Exposure to these brings forward a varied kind of health issues globally. Terbufos is one of the leading OPCs used worldwide. The present study investigates the cardiac effect of no observable dose of a metabolite of terbufos, terbufos-sulfone (TS), under non-diabetic and streptozotocin-induced diabetic condition. One hundred nanomoles per rat (1/20 of LD50) was administered intraperitoneally to adult male Wister rats daily for fifteen days. The left ventricle was collected for ultrastructural changes by transmission electron microscopy. The blood samples were collected for biochemical tests including RBC acetylcholinesterase, creatinine kinase (CK), lactate dehydrogenase (LDH), cholesterol, high density lipoprotein (HDL), low density lipoprotein (LDL), triglycerides, ALT, AST, and GGT. The study revealed about 10 % inhibition of RBC-AChE in two weeks of TS treatment in non-diabetic rats whereas RBC-AChE activity was significantly decreased in diabetic TS treated rats. CK, LDH, and triglycerides were significantly higher in diabetic TS treated rats. Electron microscopy of the heart showed derangement and lesions of the mitochondria of cardiomyocytes in the TS treated groups. The present study concludes that a non-lethal dose of TS causes cardiac lesions which exacerbate under diabetic condition. Biochemical tests confirmed the ultrastructural changes. It is concluded that a non-lethal dose of TS may be a risk factor for a cardiovascular disease, which may be fatal under diabetic condition.
authors.forename: Syed M
authors.initials: SM
authors.lastname: Nurulain
authors.forename: Mohamed
authors.initials: M
authors.lastname: Shafiullah
authors.forename: Javed
authors.initials: J
authors.lastname: Yasin
authors.forename: Abdu
authors.initials: A
authors.lastname: Adem
authors.forename: Juma Al
authors.initials: JA
authors.lastname: Kaabi
authors.forename: Saeed
authors.initials: S
authors.lastname: Tariq
authors.forename: Ernest
authors.initials: E
authors.lastname: Adeghate
authors.forename: Shreesh
authors.initials: S
authors.lastname: Ojha
mesh_terms: D000328:Adult; D000818:Animals; D002318:Cardiovascular Diseases / Q000209:etiology*; D003921:Diabetes Mellitus, Experimental / Q000503:physiopathology*; D004195:Disease Models, Animal; D006352:Heart Ventricles / Q000293:injuries*; D006801:Humans; D008297:Male; D009946:Organothiophosphorus Compounds / Q000097:blood* / Q000378:metabolism / Q000633:toxicity*; D051381:Rats; D017208:Rats, Wistar
chemical_list: D009946:Organothiophosphorus Compounds